(Approval lapsed) NYXOID naloxone 1.8mg nasal spray solution in a single-dose container (UK)
Section 19A approved medicine
(Approval lapsed) NYXOID naloxone 1.8mg nasal spray solution in a single-dose container (UK)
Section 19A approval holder
Pro Pharmaceuticals Group Pty Ltd ABN 20 605 457 430
Phone
1300 077 674
Approved until
Status
Expired
Medicines in short supply/unavailable
NYXOID naloxone hydrochloride dihydrat 2.2mg - ARTG 309381
Indication(s)
Nyxoid is intended as part of the emergency treatment for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in:
- the home or other non-medical setting
- a health facility setting For this reason, Nyxoid should be carried by persons at risk of, or likely to witness such events. Nyxoid is indicated in adults and adolescents aged 14 years and over.
Images
